| Huang Houston Guobin | 10-Jan-25 | | INED | | |
| Tong Shaojing | 28-Sep-23 | | CFO, CoSec | | |
| Chen Yunjin | 05-May-22 | | INED | | |
| Hao Xianjing | 11-May-20 | | INED | | |
| Li Yupeng | 11-May-20 | | Sup | | |
| Li Zhuanglin | 11-May-20 | | Sup | | |
| Ren Guangke | 11-May-20 | | ChSup | | |
| Su Xiaodi | 11-May-20 | | NED | | |
| Tam Vivien Pak Yu | 11-May-20 | | CoSec | | |
| Wang Liqiang | 11-May-20 | | NED | | |
| Wang Weidong | 21-Jun-19 | | Ch | | |
| Wang Weidong | 30-Oct-13 | | ED | | |
| Fang Jianmin | 16-Oct-08 | | CEO, Co-Fdr | | |
| Lin Jian | 04-Jul-08 | | ED | | |
| Wang Weidong | | 26-May-25 | MbNC | | The change was made in response to the amended Corporate Governance Code and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, effective July 1, 2025, to strengthen the effectiveness and diversity of the Board and enhance good corporate governance practice. |
| He Ruyi | 11-May-20 | 06-Feb-25 | ED | | Due to personal career development, Dr. He Ruyi has tendered his resignation. He has confirmed that he has no disagreement with the Company, the Board and the management of the Company, and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company. |
| Ma Lan | 01-Jun-21 | 10-Jan-25 | INED | | Dr. Ma ceased to be an independent non-executive Director, the chairman of the Nomination Committee and a member of the Strategy Committee upon conclusion of the EGM. Dr. Ma has confirmed that she has no disagreement with the Board and that there is no other matter in relation to her resignation that needs to be brought to the attention of the Shareholders. |
| Li Jia | 11-May-20 | 04-Sep-23 | CFO, CoSec | | Due to his personal career development |
| Yu Shanshan | 11-May-20 | 05-May-22 | INED | | |
| Babiuk Lorne Alan | 11-May-20 | 01-Jun-21 | INED | | |
